Situationmaterial
FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer
Carried more widely than almost anything else in the last 30 days
◆ Sectors
Biotech
◆ Where
United States
◆ Timeline
- 26 August 2026FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancerfda.gov
- 27 August 2026FDA approves life-extending pancreatic cancer drug Rasonqueusatoday.com
- 28 August 2026FDA approves breakthrough pancreatic cancer drug Rasonquefoxnews.com
- 29 August 2026'I'm still here:' South Florida patients see early promising results from new pancreatic cancer pillsun-sentinel.com
- 30 August 2026'Miracle drug' used by Sasse receives FDA approvalpressreader.com
- 31 August 2026Karmanos Now Offers FDA-Approved Daraxonrasib (Rasonque) for Metastatic Pancreatic Cancersg.finance.yahoo.com
- 2 September 2026Breakthrough cancer treatment being researched in Arizona receives FDA approval12news.com
- 3 September 2026New pancreatic cancer drug gives South Portland man hope for longer lifepressherald.com
- 5 September 2026Revolution Medicines drug Rasonoque shows promise against lung cancerfox.com
◆ Connected developments
Situations Wire finds semantically close to this one. Proximity, not cause.
◆ Share
◆ Wire has not analysed this situation yet
Below is every report Wire has gathered on this event, and the situations it connects to. The deeper analysis — why it happened, what changed, what would prove it wrong — is not written yet, so nothing here claims it.
◆ Evidence
59 reports · 51 domains